Antimicrobial peptides in inflammatory bowel disease

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Antimicrobial peptides are one of the most ancient forms of host defense in nature. In the mammalian intestine, clear and compelling evidence supports that antimicrobial peptides play two fundamental roles: protection from enteric pathogens and shaping the composition of the colonizing microbiota. These functions likely hold relevance to host–microbe interactions that underlie inflammatory bowel disease (IBD) pathogenesis. Epithelial cells of the human intestine express a collection of antimicrobial peptides that have overlapping and complementary activities. These peptides have substantial influence on the intestinal microbiota. Prevailing theories on the pathogenesis of IBD invoke a role for the detrimental effects of intestinal microbes in the initiation and/or propagation of mucosal inflammation. The most abundant antimicrobial peptides in the human intestine are α(alpha)-defensin peptides, most notably human defensin (HD)–5 and HD6. Other abundant polypeptides, which are larger in size but with fundamentally similar physiological roles, are lysozyme, secretory phospholipase A2, and the C–type lectin RegIIIα. Specialized epithelial cells named Paneth cells produce and secrete vast quantities of these various antimicrobial peptides. Evidence supports that reduced Paneth cell α–defensin expression may be a key factor in the pathogenesis of ileal Crohn's disease, a subgroup of IBD. Furthermore, several susceptibility genes for IBD may manifest their effects, in part, through compromise of Paneth cell antimicrobial peptide production or function. For example, the microbial sensor NOD–2, the autophagy protein ATG16L1, the endoplasmic reticulum stress responder XBP–1, the calcium–dependent potassium channel KCa3.1 and the transcription factor TCF4 are all important in Paneth cell function. While not proven, it is likely that the Paneth cell dysfunction, which may result from variants in genes encoding these or other Paneth cell proteins, may substantially contribute to IBD pathogenesis.

Original languageEnglish (US)
Title of host publicationCrohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach
PublisherSpringer US
Pages119-132
Number of pages14
ISBN (Electronic)9781461409984
ISBN (Print)9781461409977
DOIs
StatePublished - Jan 1 2012

Fingerprint

Inflammatory Bowel Diseases
Paneth Cells
Peptides
Defensins
Intestines
Ileal Diseases
Epithelial Cells
Secretory Phospholipase A2
Endoplasmic Reticulum Stress
Potassium Channels
Microbiota
Autophagy
Muramidase
Lectins
Crohn Disease
Genes
Proteins
Transcription Factors
Inflammation

Keywords

  • Antimicrobial peptide
  • Candidatus arthromitis
  • Crohn's disease
  • Cryptdin-related sequences
  • Dysbiosis
  • Hepatocarcinoma-intestine-pancreas
  • KCa 3.1
  • Lysozyme
  • Matrix metalloproteinase-7
  • Microbiota
  • NOD2
  • Pancreatitis-associated protein
  • Paneth cell
  • PLA2
  • Salmonella
  • Secretory phospholipase
  • Segmented filamentous bacteria
  • Tcf-4
  • Ulcerative colitis
  • X-box-binding protein 1
  • α(alpha)-Defensin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Bevins, C. L. (2012). Antimicrobial peptides in inflammatory bowel disease. In Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach (pp. 119-132). Springer US. https://doi.org/10.1007/978-1-4614-0998-4_8

Antimicrobial peptides in inflammatory bowel disease. / Bevins, Charles L.

Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach. Springer US, 2012. p. 119-132.

Research output: Chapter in Book/Report/Conference proceedingChapter

Bevins, CL 2012, Antimicrobial peptides in inflammatory bowel disease. in Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach. Springer US, pp. 119-132. https://doi.org/10.1007/978-1-4614-0998-4_8
Bevins CL. Antimicrobial peptides in inflammatory bowel disease. In Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach. Springer US. 2012. p. 119-132 https://doi.org/10.1007/978-1-4614-0998-4_8
Bevins, Charles L. / Antimicrobial peptides in inflammatory bowel disease. Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach. Springer US, 2012. pp. 119-132
@inbook{e0971743f0964f3d92e5c6d9cb5bac5b,
title = "Antimicrobial peptides in inflammatory bowel disease",
abstract = "Antimicrobial peptides are one of the most ancient forms of host defense in nature. In the mammalian intestine, clear and compelling evidence supports that antimicrobial peptides play two fundamental roles: protection from enteric pathogens and shaping the composition of the colonizing microbiota. These functions likely hold relevance to host–microbe interactions that underlie inflammatory bowel disease (IBD) pathogenesis. Epithelial cells of the human intestine express a collection of antimicrobial peptides that have overlapping and complementary activities. These peptides have substantial influence on the intestinal microbiota. Prevailing theories on the pathogenesis of IBD invoke a role for the detrimental effects of intestinal microbes in the initiation and/or propagation of mucosal inflammation. The most abundant antimicrobial peptides in the human intestine are α(alpha)-defensin peptides, most notably human defensin (HD)–5 and HD6. Other abundant polypeptides, which are larger in size but with fundamentally similar physiological roles, are lysozyme, secretory phospholipase A2, and the C–type lectin RegIIIα. Specialized epithelial cells named Paneth cells produce and secrete vast quantities of these various antimicrobial peptides. Evidence supports that reduced Paneth cell α–defensin expression may be a key factor in the pathogenesis of ileal Crohn's disease, a subgroup of IBD. Furthermore, several susceptibility genes for IBD may manifest their effects, in part, through compromise of Paneth cell antimicrobial peptide production or function. For example, the microbial sensor NOD–2, the autophagy protein ATG16L1, the endoplasmic reticulum stress responder XBP–1, the calcium–dependent potassium channel KCa3.1 and the transcription factor TCF4 are all important in Paneth cell function. While not proven, it is likely that the Paneth cell dysfunction, which may result from variants in genes encoding these or other Paneth cell proteins, may substantially contribute to IBD pathogenesis.",
keywords = "Antimicrobial peptide, Candidatus arthromitis, Crohn's disease, Cryptdin-related sequences, Dysbiosis, Hepatocarcinoma-intestine-pancreas, KCa 3.1, Lysozyme, Matrix metalloproteinase-7, Microbiota, NOD2, Pancreatitis-associated protein, Paneth cell, PLA2, Salmonella, Secretory phospholipase, Segmented filamentous bacteria, Tcf-4, Ulcerative colitis, X-box-binding protein 1, α(alpha)-Defensin",
author = "Bevins, {Charles L}",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-0998-4_8",
language = "English (US)",
isbn = "9781461409977",
pages = "119--132",
booktitle = "Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach",
publisher = "Springer US",

}

TY - CHAP

T1 - Antimicrobial peptides in inflammatory bowel disease

AU - Bevins, Charles L

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Antimicrobial peptides are one of the most ancient forms of host defense in nature. In the mammalian intestine, clear and compelling evidence supports that antimicrobial peptides play two fundamental roles: protection from enteric pathogens and shaping the composition of the colonizing microbiota. These functions likely hold relevance to host–microbe interactions that underlie inflammatory bowel disease (IBD) pathogenesis. Epithelial cells of the human intestine express a collection of antimicrobial peptides that have overlapping and complementary activities. These peptides have substantial influence on the intestinal microbiota. Prevailing theories on the pathogenesis of IBD invoke a role for the detrimental effects of intestinal microbes in the initiation and/or propagation of mucosal inflammation. The most abundant antimicrobial peptides in the human intestine are α(alpha)-defensin peptides, most notably human defensin (HD)–5 and HD6. Other abundant polypeptides, which are larger in size but with fundamentally similar physiological roles, are lysozyme, secretory phospholipase A2, and the C–type lectin RegIIIα. Specialized epithelial cells named Paneth cells produce and secrete vast quantities of these various antimicrobial peptides. Evidence supports that reduced Paneth cell α–defensin expression may be a key factor in the pathogenesis of ileal Crohn's disease, a subgroup of IBD. Furthermore, several susceptibility genes for IBD may manifest their effects, in part, through compromise of Paneth cell antimicrobial peptide production or function. For example, the microbial sensor NOD–2, the autophagy protein ATG16L1, the endoplasmic reticulum stress responder XBP–1, the calcium–dependent potassium channel KCa3.1 and the transcription factor TCF4 are all important in Paneth cell function. While not proven, it is likely that the Paneth cell dysfunction, which may result from variants in genes encoding these or other Paneth cell proteins, may substantially contribute to IBD pathogenesis.

AB - Antimicrobial peptides are one of the most ancient forms of host defense in nature. In the mammalian intestine, clear and compelling evidence supports that antimicrobial peptides play two fundamental roles: protection from enteric pathogens and shaping the composition of the colonizing microbiota. These functions likely hold relevance to host–microbe interactions that underlie inflammatory bowel disease (IBD) pathogenesis. Epithelial cells of the human intestine express a collection of antimicrobial peptides that have overlapping and complementary activities. These peptides have substantial influence on the intestinal microbiota. Prevailing theories on the pathogenesis of IBD invoke a role for the detrimental effects of intestinal microbes in the initiation and/or propagation of mucosal inflammation. The most abundant antimicrobial peptides in the human intestine are α(alpha)-defensin peptides, most notably human defensin (HD)–5 and HD6. Other abundant polypeptides, which are larger in size but with fundamentally similar physiological roles, are lysozyme, secretory phospholipase A2, and the C–type lectin RegIIIα. Specialized epithelial cells named Paneth cells produce and secrete vast quantities of these various antimicrobial peptides. Evidence supports that reduced Paneth cell α–defensin expression may be a key factor in the pathogenesis of ileal Crohn's disease, a subgroup of IBD. Furthermore, several susceptibility genes for IBD may manifest their effects, in part, through compromise of Paneth cell antimicrobial peptide production or function. For example, the microbial sensor NOD–2, the autophagy protein ATG16L1, the endoplasmic reticulum stress responder XBP–1, the calcium–dependent potassium channel KCa3.1 and the transcription factor TCF4 are all important in Paneth cell function. While not proven, it is likely that the Paneth cell dysfunction, which may result from variants in genes encoding these or other Paneth cell proteins, may substantially contribute to IBD pathogenesis.

KW - Antimicrobial peptide

KW - Candidatus arthromitis

KW - Crohn's disease

KW - Cryptdin-related sequences

KW - Dysbiosis

KW - Hepatocarcinoma-intestine-pancreas

KW - KCa 3.1

KW - Lysozyme

KW - Matrix metalloproteinase-7

KW - Microbiota

KW - NOD2

KW - Pancreatitis-associated protein

KW - Paneth cell

KW - PLA2

KW - Salmonella

KW - Secretory phospholipase

KW - Segmented filamentous bacteria

KW - Tcf-4

KW - Ulcerative colitis

KW - X-box-binding protein 1

KW - α(alpha)-Defensin

UR - http://www.scopus.com/inward/record.url?scp=84912140679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912140679&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-0998-4_8

DO - 10.1007/978-1-4614-0998-4_8

M3 - Chapter

AN - SCOPUS:84912140679

SN - 9781461409977

SP - 119

EP - 132

BT - Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach

PB - Springer US

ER -